Skip to main content
. 2022 Jun 17;13:885218. doi: 10.3389/fneur.2022.885218

Figure 5.

Figure 5

Brain MRI lesion evolution in patients with MOGAD, AQP4-IgG+NMOSD, and MS on FLAIR images. [(A,B): MOGAD] Acute bilateral large T2-hyperintensities of middle cerebellar peduncles (right > left) (A1, arrowheads), and in the thalamus and cortico-spinal tract bilaterally (B1, arrowheads). All T2-lesions had resolved completely by the time of follow-up MRI (A2, B2). [(C D): AQP4-IgG+NMOSD] Acute T2-hyperintense lesion around the 4th ventricle (C1, arrowhead), resolving to nearly undetectable at follow-up MRI (C2, arrowhead); and lesions involving the corpus callosum (D1, arrowheads), undergoing reduction in size without resolution on follow-up MRI (D2, arrowheads). [(E,F): MS] Acute T2-hyperintense white matter lesions (E1, F1, arrowheads), reduced in size but still visible on follow-up MRI (E2, F2, arrowheads). MOGAD, myelin oligodendrocyte glycoprotein antibody-associated disease; AQP4-IgG+NMOSD, aquaporin-4-IgG seropositive neuromyelitis optica spectrum disorder; MS, multiple sclerosis. FLAIR, fluid attenuated inversion recovery.